For the first time, stem cell presents a hope for the Pulmonary Hypertension. Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), announced nine month follow up results for the first patient treated with engineered stem cells in a clinical study of primary pulmonary hypertension. Moreover, the stem cells were taken from the patient’s own blood.
Patient Karl Wagner, age 46 of Macon, Georgia, underwent the Adult Stem Cell therapy in February 2008. Wagner says since being diagnosed with pulmonary hypertension, he was on a rapid decline. Dr. Hector Jose Rosario, Professor of Cardiology at PCUSM and Director of Cardiovascular Therapy for Regenocyte’s Dominican division, says Wagner’s reduction in pulmonary artery mean pressure from 41mmHg (severe pulmonary hypertension) to 24 mmHg (normal) is extremely encouraging, and to date, the other patients in the study are following the same pattern.
Athina Kyritsis, M.D. and chair of Regenocyte’s Scientific Advisory Board, says the work announced today is based upon several years of Regenocyte’s clinical experience in the treatment of cardiac and vascular disease using Autologous Adult Stem Cell therapy.
Zannos Grekos, M.D., Assistant Clinical Professor of Cardiology at Nova Southeastern University and head of the international team that developed the stem cell treatment protocol said that , the clinical study is a collaborative effort amongst physicians at Regenocyte Therapeutic, a Florida-based stem cell clinic; researchers from TheraVitae, a biotechnology company in Tel Aviv, Israel; and physicians from Regenocyte’s Dominican Republic division.
The patient’s base line and follow up testing is being conducted in part by Mayo Clinic, Jacksonville, Florida. He says,
“It goes against traditional theory that we should try to fix the existing pulmonary vasculature, but we are generating new blood vessels with impressive results.”
Regenocyte Therapeutic is one of the only clinically treating Adult Stem Cell Therapy centers in the world today. An experienced team of Board Certified physicians use cutting edge technology, paralleling that of Universities and major medical facilities, to prolong and improve the quality of life of patients living with diseases including Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Kidney Disease, Ischemic Heart Disease, Pulmonary Disease, and Early Senile Dementia. For patient information or consultation, call 866-216-5710.